- Home
- FPAY vs ALLR Comparison
FPAY vs ALLR Comparison
Compare FPAY & ALLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FPAY
- ALLR
- Stock Information
- Founded
- FPAY 2003
- ALLR 2004
- Country
- FPAY United States
- ALLR United States
- Employees
- FPAY N/A
- ALLR N/A
- Industry
- FPAY Diversified Commercial Services
- ALLR Biotechnology: Pharmaceutical Preparations
- Sector
- FPAY Consumer Discretionary
- ALLR Health Care
- Exchange
- FPAY Nasdaq
- ALLR Nasdaq
- Market Cap
- FPAY 18.3M
- ALLR 21.8M
- IPO Year
- FPAY N/A
- ALLR N/A
- Fundamental
- Price
- FPAY $0.19
- ALLR $1.50
- Analyst Decision
- FPAY Strong Buy
- ALLR Strong Buy
- Analyst Count
- FPAY 2
- ALLR 1
- Target Price
- FPAY $2.25
- ALLR $9.25
- AVG Volume (30 Days)
- FPAY 1.2M
- ALLR 339.5K
- Earning Date
- FPAY 11-12-2025
- ALLR 11-13-2025
- Dividend Yield
- FPAY N/A
- ALLR N/A
- EPS Growth
- FPAY N/A
- ALLR N/A
- EPS
- FPAY N/A
- ALLR N/A
- Revenue
- FPAY $139,800,732.00
- ALLR N/A
- Revenue This Year
- FPAY $19.71
- ALLR N/A
- Revenue Next Year
- FPAY N/A
- ALLR N/A
- P/E Ratio
- FPAY N/A
- ALLR N/A
- Revenue Growth
- FPAY 19.51
- ALLR N/A
- 52 Week Low
- FPAY $0.18
- ALLR $0.61
- 52 Week High
- FPAY $2.37
- ALLR $2.35
- Technical
- Relative Strength Index (RSI)
- FPAY 21.94
- ALLR 46.56
- Support Level
- FPAY $0.18
- ALLR $1.40
- Resistance Level
- FPAY $0.38
- ALLR $1.80
- Average True Range (ATR)
- FPAY 0.06
- ALLR 0.12
- MACD
- FPAY -0.01
- ALLR -0.03
- Stochastic Oscillator
- FPAY 1.21
- ALLR 23.75
About FPAY FlexShopper Inc.
FlexShopper Inc is a financial technology company engaged in providing certain types of durable goods to consumers on a lease-to-own basis and providing lease-to-own (LTO) terms to consumers of third-party retailers and e-tailers. Its products include electronics, computers, furniture, mattresses, cameras and camcorders, audio, musical instruments, health, fitness and sports, video games, homes, gardens and tools, appliances, and vacuums on a payment, lease basis. The firm generates a majority of its revenue by leasing its products. The company enables consumers utilizing its e-commerce marketplace to shop for brand-name electronics, home furnishings, and other durable goods on a lease-to-own (LTO) basis.
About ALLR Allarity Therapeutics Inc.
Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.